@ Newsroom | SEBIO

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

Posted by on Jan 19, 2017 in Newsroom | 0 comments

ATLANTA, GA. – The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections. The Centers for Disease Control and Prevention estimates between 700,000 to 1.4 million people in the United States have chronic Hepatitis B virus infections, with an estimated 20,000 new infections every year. The research collaboration will include the design, construction and...

Read More

Georgia Bio Deals of the Year Spotlight Financings, Acquisitions and IPO

Posted by on Jan 19, 2017 in Newsroom | 0 comments

ATLANTA, GA. – Georgia Bio announced its 2017 Deals of the Year for pharmaceutical, biotechnology, healthcare IT and medical device companies in the following categories – private financing, initial public offering, public financing, and acquisitions – reflecting a broad range of activity. The annual Deal of the Year awards recognize transactions by life sciences companies in Georgia such as financings, partnering agreements and government grants that are significant to the state’s industry development. Deals of the Year are awarded to one or more companies or institutions for...

Read More

Avalon Healthcare Solutions Raises Additional Capital to Drive Growth

Posted by on Jan 10, 2017 in Newsroom | 0 comments

TAMPA, FL. – Avalon Healthcare Solutions, the leader in technology-enabled laboratory benefit management, today announced a third round of capital investment in the company. Mosaic Health Solutions (Mosaic), BlueCross BlueShield of South Carolina, and Francisco Partners are investors in the round. Echo Health Ventures (Echo) will administer this investment for Mosaic. Avalon is experiencing rapid growth as more health insurers express interest in the company’s services. The new capital will be used to enhance Avalon’s comprehensive laboratory benefits management solution...

Read More

Cavion Raises $26.1 MM Series A Financing

Posted by on Jan 9, 2017 in Newsroom | 0 comments

CHARLOTTESVILLE, VA. – Cavion, Inc., announced today the closing of a $26.1 million venture financing. Lilly Ventures and Novartis Venture Fund co-led the investment round in tandem with Enso Ventures and additional participation of existing investors. Cavion is a clinical stage biotechnology company developing T-type calcium channel (Cav3) modulators for the treatment of neurological diseases and cancer. “We welcome the backing of Novartis Venture Fund, Lilly Ventures, and Enso,” said Andrew Krouse, President and CEO of Cavion. “They bring a superior track record of success...

Read More

Jupiter Orphan Therapeutics Secures Financing and Adds Board Member

Posted by on Jan 6, 2017 in Newsroom | 0 comments

JUPITER, FL. – Jupiter Orphan Therapeutics, Inc., announced that it has secured a $2 million financing commitment from Tarnagulla Ventures, Melbourne, Australia (“Tarnagulla”). The financing is in the form of a convertible note with the first $1 million paid out immediately and the remaining $1 million to be paid when certain milestones are met. In addition, JOT has received $500,000 in an equity financing through a charity based financing group. Ms. Natalie McNamee will represent Tarnagulla on the Board of Directors at JOT. “This is a great step for JOT to get...

Read More

Bardy Diagnostics Announces Growth Capital Funding

Posted by on Jan 6, 2017 in Newsroom | 0 comments

CHARLOTTE, N.C. – Bardy Diagnostics, Inc., which has developed and is commercializing the Carnation Ambulatory Monitor (“CAM™”), the world’s smallest and lightest P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, today announced that it has raised a significant round of growth capital from experienced healthcare investors SV Life Sciences Advisers (“SVLS”), Health Enterprise Partners (“HEP”), Ascension Ventures (“AV”) and Square 1 Bank, a division of Pacific Western Bank (“Square 1”).  The...

Read More